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Purpose. PillCam SB2 capsule endoscopy, an upgraded version of widely used SB capsule endoscopy, was examined for its
performance by comparing with SB. Methods. Examinees with various indications were enrolled for SB2 capsule endoscopy;
subjects were also enlisted for the old SB capsule endoscopy. Number of photo images containing papilla of Vater was counted.
Shape of the papilla seen in each image was evaluated by scoring 3 (fully observable papilla), 2 (more than half outline), or 1
(less than half outline) points. Images obtained from SB and SB2 were also subjectively compared; resolution and brightness were
scored by six experienced endoscopists. Results. Baseline characteristics of two study groups (n = 30 each) were not signiﬁcantly
diﬀerent. Number of images of the papilla revealed to show similar results between SB (3.1 ± 1.1, range 1∼5) and SB2 (3.1 ± 1.5,
range 1∼8) (P = 0.62). The maximum points of outline of papilla evaluated from each subject were also similar between two
groups. New SB2 revealed to be superior to SB in terms of resolution but not signiﬁcantly diﬀerent in brightness. Conclusion.O u r
study showed that superiority of SB2 over SB is rather marginal on examining duodenal papilla.
1.Introduction
Wireless capsule endoscopy (WCE) is widely used for
diagnosing various small bowel diseases. However, this
convenient diagnostic tool has several inherent drawbacks;
inability of biopsy, lengthy time for interpretation, lack of
active control of the device that just ﬂoats about the gut in
accordance with peristalsis, and so forth. Relatively narrow
visual ﬁeld and ﬁxed image contrast also leads to insuﬃcient
visualization of the intestinal mucosa, hindering precise
diagnosis of various endoscopic ﬁndings. In our previous
report that studied the limited ability of WCE to detect
duodenal papilla, we proved that a technologic improvement
of WCE is essential [1]. This study additionally delivered
another message, that is, true diagnostic yield of WCE is
unexpectedly not that high, revealing a detection rate of only
43.6%.
PillCam SB2 video capsule is a recently released version
of PillCam SB video capsule. It is characterized with a wider
visual ﬁeld, automatic light control, and new capsule lenses,
therefore enabling improved visualization of small bowel
mucosa. After release of the PillCam SB2 to the local market
of Korea, authors performed an investigation of comparing
images and diagnostic yield of SB2 capsule with the old
model SB, using normally positioned duodenal papilla as a
landmark.
2. Methods
PillCam SB and SB2 capsule endoscopy was each performed
to examinees with various indications. Patients with follow-
ing conditions were excluded: previous gastrointestinal (GI)
tract surgery including resection, suspicious GI obstruction,
comorbid serious cardiopulmonary or renal diseases (i.e.,
heartfailure,acutemyocardialinfarction,dysrhythmia,renal
insuﬃciency, etc.), and refusal of participation. Subjects
were all veriﬁed that no current medication was being
administered such as iron supplements. All participants
were provided of detailed explanation of the concept and
design of study and gave a written informed consent before2 Gastroenterology Research and Practice
investigation. Before performing two diﬀerent versions of
WCE, all of the examinees ﬁrst veriﬁed their normal posi-
tion of duodenal papilla via esophagogastroduodenoscopy.
Subjects were randomly assigned to each study group by
usingacomputerizedprogram.Thisstudywasexaminedand
approvedbytheinstitutionalreviewboardofourinstitution.
Bowel preparation was done by drinking 4 liters of
polyethylene glycol (PEG) solution early in the morning.
Capsule was swallowed after verifying clear watery defeca-
tion, and examinees were allowed to take ﬂuid 2 hours after
theingestionofcapsule.Subjectswereaskedtostayinbedon
asupinepositionduringswallowingcapsuleandafterstartof
capsule endoscopy for 3 hours. Examinees were allowed for
ambulation thereafter. After removing the digital recording
device, simple abdominal radiographs were taken from all
participants to verify discharge of capsule from subjects’ GI
tract.
Diagnostic yield was evaluated in three aspects: (1)
counting the number of digital photographic images with
a view of duodenal papilla, (2) grading the maximum
proportion of papillary outline in picture, and (3) scoring
the resolution and brightness. In detail, papillary outline
was graded as 3 (full), 2 (more than half), or 1 (less than
half). If more than one image of papilla was captured from a
subject, the maximum appearance of papilla was evaluated
for scoring. Resolution and brightness were scored as 0
(low), 1 (medium), or 2 (high resolution or brightness),
respectively, by six experienced gastroenterologists after
watching a short video clip from two SB and two SB2
capsules, respectively. In order to blind the speciﬁc type
of capsule from gastroenterologists, octagonal outline of
SB2 capsule was hidden with black-colored paper onto the
computer screen.
Quantitative data were reviewed by mean ± standard
deviation (SD) or number and analyzed by the t-test.
Categorical data were shown as a frequency (percentage)
and handled by χ2 test. Statistical analysis was done using a
computerized statistical program (SPSS for Windows 12.0,
SPSS Inc., Chicago, IL, USA). P values less than 0.05 were
considered as a statistically signiﬁcant result.
3. Results
The numbers of participants who prospectively enrolled
and performed the SB and SB2 capsule endoscopy were
30 subjects, respectively, with indications (Table 1). Baseline
characteristics such as sex or age were not statistically
diﬀerent. There was also no signiﬁcant diﬀerence in terms of
indication. All participants veriﬁed no capsule remaining in
GI tract on simple abdominal radiographs. From each study
group, two participants, respectively, showed suboptimal
bowel preparation of each group, respectively, and these
subjects were indicated to drink another 2 liters of PEG
solution, resulting in satisfactory preparation of clear watery
defecatory passage.
Table 2 summarizes the result of detection rate, number
of images, and scoring of papilla of Vater of two study
groups. SB and SB2 group revealed to have a papillary
detection rate of 43.3% and 50.0%, respectively, with no
Table 1: Baseline characteristics and indications for wireless
capsule endoscopy.
SB
(n = 30)
SB2
(n = 30) P value
Sex (M/F) 14/16 15/15 NS
Age 46.1 ±10.15 1 .4 ±9.2N S
Healthy volunteers 3 2 NS
Obscure GIB 18 19 NS
Abdominal pain 5 6 NS
Chronic diarrhea 4 3 NS
(SB: small bowel capsule endoscope, SB2: small bowel capsule endoscope
version 2, GIB: gastrointestinal bleeding, and NS: not signiﬁcant)
∗Values shown as mean ± SD or No.
Table 2: Results of wireless capsule endoscopy comparing SB and
SB2 capsule.
SB SB2 P value
Detection rate (%) 43.3
(13/30)
50.0
(15/30) 0.796
N o .o fi m a g e so fp a p i l l a 3 .1 ±1.13 .1 ±1.5 0.571
Image grading (max)
3 points 4/13 4/15
2 points 5/13 7/15
1 point 4/13 4/15
∗Values shown as mean ± SD or No. max: maximum.
Table 3: Subjective scoring of resolution and brightness on SB and
SB2 groups.
Parameters SB
(n = 12)
SB2
(n = 12) P value
Resolution 0.93 ±0.62 1.55 ±0.40 0.001
Brightness 1.21 ±0.70 1.57 ±0.51 0.165
∗Values shown as mean ± SD or No.
signiﬁcant statistical diﬀerence (P = 0.796). Number of
photographic images containing the papilla also showed no
statistical diﬀerence between two study groups (P = 0.571).
The maximum point of evaluating the shape of papilla was
collected, and scores marked from each participant were
statistically similar between SB and SB2 study group. Some
representative WCE images are illustrated on Figure 1.
Although SB2 capsule was superior to SB in terms of
scoring of resolution (P = 0.001), scoring of brightness of
SB and SB2 capsule revealed no signiﬁcant diﬀerence (P =
0.165) (Table 3). In short, lack of improvement in brightness
must be noted, whereas resolution exempliﬁed signiﬁcant
diﬀerence between the two study groups.
4. Discussion
According to our investigation, PillCam SB2 capsule en-
doscopy failed to show major superiority over SB on
observing duodenal papilla. The performance of SB2 wasGastroenterology Research and Practice 3
Figure 1: Representative images and scorings of papillary outline (marked on bottom right) of each capsule endoscopy (upper and lower
panel for SB2 and SB, resp.). The octangular outline of SB2 images were hidden with black-colored paper in order not to be discerned by
experienced gastroenterologists.
rather similar compared with the old version SB in several
aspects as shown. Therefore, another technological step-
up seems to be more important altogether with bowel
preparation or visual obstacles (bubbles, bile, or debris),
such as enhanced performance of photograph numbers per
second. For example, one recent study addressed their result
of digital capsule endoscopic images taken at a slower speed
(i.e., 1 frame per second) does not deteriorate the overall
performance of WCE, compared with the ordinary study
speed of 2 frames per second [2]. A larger number of cases
will verify our contention, but even as small participants, our
study may give cautions to some physicians’ blind optimism
toward new technology and make them not to lose track
of criticizing mere technological improvements. One recent
investigation proved the limitation of faster image capture
rates or two cameras on detecting a speciﬁc ﬁnding during
WCE [3]. in contrast, some researchers refuted this study
arguing that “double-headed” esophageal capsules and a
faster viewing speed seems to retain a possible advantage
[4]. Some investigators studied the performance of WCE
[5] in response to our previous report [1], but omission
of the exact appearance of papilla via EGD may have led
to a lower detection rate of 10.4%. Although all subjects
participated in various studies have a papilla, size and shape
of papilla vary (see Figure 1) and sometimes a periampullary
structural change such as diverticulum may inﬂuence the
exact detection rate of papilla. Besides, there is very rapid
transit of the capsule through the duodenum, and although
it is usually clean without food or other debris, the papilla is
missed.
It is also noteworthy that that WCE is not indicated for
examining the duodenal papilla according to the current
guidelines [6, 7]. The indications for the performance of
capsule endoscopy (i.e., obscure gastrointestinal bleeding,
establishedorsuspectedCrohn’sdisease,etc.)arealreadywell
known and being adopted in the clinical ﬁeld; our purpose
is not to add a new indication, but rather to use the papilla
in order to compare the images taken by the two devices
(Pillcam SB1 versus 2).
Since the advent on year 2000, WCE has changed the
diagnosis and management of many diseases developing
in small intestine. Many researchers studied the diagnostic
power of this novel device, and investigators reported the
incremental diagnostic yield in a spectrum of 39∼90%
in terms of obscure/occult gastrointestinal bleeding [8,
9]; one study group elucidated the estimated diagnostic
yield of up to 91.1% [10]. However, the sensitivity and
speciﬁcity presented on some previous studies lack conﬁ-
dence intervals [10]. That is, diagnostic accuracy should
be presented with conﬁdence interval in order not to
make a considerable diﬀerence to a clinician’s interpre-
tation of the ﬁnding of a speciﬁc study [11]. For his
reason, and also because of current shortage of estab-
lished diagnostic accuracy, diagnostic yield is still used
to represent the goodness of WCE instead of diagnostic
accuracy.4 Gastroenterology Research and Practice
While duodenal papilla may not be a good landmark
because of its angular position and relatively swift transition
of capsule in duodenum, it still can serve as the worst case
of a possible miss rate because of similar shape and size with
commonlymissedlesions(angiodysplasias,smallulcers,etc.)
[1]. Our results diﬀer from previous reports studied with the
oldmodel[10]orthesamenewversionalikewedid[12].We
believe our study fulﬁlls the role as a pilot study of the new
version of device, prompting further studies investigating
a larger number of subjects for clinical validation of this
renewed apparatus.
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